Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.70 -0.01 (-2.06%)
As of: Oct 21, 2026 · 2:47 PM EDT

Milestone Pharmaceuticals (MIST) Non-Current Debt (2023)

Updated

Analysis

Milestone Pharmaceuticals (MIST) Non-Current Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 62.48 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 60.50 Bn
10 Milestone Pharmaceuticals 97.60 Mn -73.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 50.00 Mn
API Access

Milestone Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MIST&period=max&api_key=YOUR_API_KEY